Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

The safety of calcium channel blockers in human pregnancy: a prospective, multicenter cohort study.

Magee LA, Schick B, Donnenfeld AE, Sage SR, Conover B, Cook L, McElhatton PR, Schmidt MA, Koren G.

Am J Obstet Gynecol. 1996 Mar;174(3):823-8.

PMID:
8633650
2.

The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study.

Weber-Schoendorfer C, Hannemann D, Meister R, Eléfant E, Cuppers-Maarschalkerweerd B, Arnon J, Vial T, Rodriguez-Pinilla E, Clementi M, Robert-Gnansia E, De Santis M, Malm H, Dolivo A, Schaefer C.

Reprod Toxicol. 2008 Sep;26(1):24-30. doi: 10.1016/j.reprotox.2008.05.065. Epub 2008 Jun 7.

PMID:
18585452
3.

Safety of haloperidol and penfluridol in pregnancy: a multicenter, prospective, controlled study.

Diav-Citrin O, Shechtman S, Ornoy S, Arnon J, Schaefer C, Garbis H, Clementi M, Ornoy A.

J Clin Psychiatry. 2005 Mar;66(3):317-22.

PMID:
15766297
4.

Pregnancy outcome after gestational exposure to mebendazole: a prospective controlled cohort study.

Diav-Citrin O, Shechtman S, Arnon J, Lubart I, Ornoy A.

Am J Obstet Gynecol. 2003 Jan;188(1):282-5.

PMID:
12548230
5.

The safety of mesalamine in human pregnancy: a prospective controlled cohort study.

Diav-Citrin O, Park YH, Veerasuntharam G, Polachek H, Bologa M, Pastuszak A, Koren G.

Gastroenterology. 1998 Jan;114(1):23-8.

PMID:
9428214
6.

Pregnancy outcome after gestational exposure to metronidazole: a prospective controlled cohort study.

Diav-Citrin O, Shechtman S, Gotteiner T, Arnon J, Ornoy A.

Teratology. 2001 May;63(5):186-92.

PMID:
11320529
7.

Pregnancy outcome following first-trimester exposure to zopiclone: a prospective controlled cohort study.

Diav-Citrin O, Okotore B, Lucarelli K, Koren G.

Am J Perinatol. 1999;16(4):157-60.

PMID:
10458526
8.

Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies.

Park-Wyllie L, Mazzotta P, Pastuszak A, Moretti ME, Beique L, Hunnisett L, Friesen MH, Jacobson S, Kasapinovic S, Chang D, Diav-Citrin O, Chitayat D, Nulman I, Einarson TR, Koren G.

Teratology. 2000 Dec;62(6):385-92.

PMID:
11091360
9.

Safety of first trimester exposure to histamine H2 blockers. A prospective cohort study.

Magee LA, Inocencion G, Kamboj L, Rosetti F, Koren G.

Dig Dis Sci. 1996 Jun;41(6):1145-9.

PMID:
8654145
10.

Pregnancy outcome after in utero exposure to colchicine.

Diav-Citrin O, Shechtman S, Schwartz V, Avgil-Tsadok M, Finkel-Pekarsky V, Wajnberg R, Arnon J, Berkovitch M, Ornoy A.

Am J Obstet Gynecol. 2010 Aug;203(2):144.e1-6. doi: 10.1016/j.ajog.2010.02.063. Epub 2010 Jul 1.

PMID:
20579964
11.

Pregnancy outcome of women inadvertently exposed to ribostamycin during early pregnancy: a prospective cohort study.

Lee SW, Han JY, Choi JS, Chung JH, Kim MY, Yang JH, Koong MK, Nava-Ocampo AA, Koren G.

Reprod Toxicol. 2009 Apr;27(2):196-8. doi: 10.1016/j.reprotox.2008.12.008. Epub 2008 Dec 31.

PMID:
19162171
12.

Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study.

Gur C, Diav-Citrin O, Shechtman S, Arnon J, Ornoy A.

Reprod Toxicol. 2004 Jan-Feb;18(1):93-101.

PMID:
15013068
13.

Prospective assessment of pregnancy outcomes after first-trimester exposure to fluconazole.

Mastroiacovo P, Mazzone T, Botto LD, Serafini MA, Finardi A, Caramelli L, Fusco D.

Am J Obstet Gynecol. 1996 Dec;175(6):1645-50.

PMID:
8987954
14.

Pregnancy outcome after gestational exposure to loratadine or antihistamines: a prospective controlled cohort study.

Diav-Citrin O, Shechtman S, Aharonovich A, Moerman L, Arnon J, Wajnberg R, Ornoy A.

J Allergy Clin Immunol. 2003 Jun;111(6):1239-43.

PMID:
12789223
15.

Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study.

Chun-Fai-Chan B, Koren G, Fayez I, Kalra S, Voyer-Lavigne S, Boshier A, Shakir S, Einarson A.

Am J Obstet Gynecol. 2005 Mar;192(3):932-6.

PMID:
15746694
16.

The risk of limb deficiencies and other congenital abnormalities in children exposed in utero to calcium channel blockers.

Sørensen HT, Czeizel AE, Rockenbauer M, Steffensen FH, Olsen J.

Acta Obstet Gynecol Scand. 2001 May;80(5):397-401.

PMID:
11328214
17.

Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study.

Schaefer C, Hannemann D, Meister R, Eléfant E, Paulus W, Vial T, Reuvers M, Robert-Gnansia E, Arnon J, De Santis M, Clementi M, Rodriguez-Pinilla E, Dolivo A, Merlob P.

Thromb Haemost. 2006 Jun;95(6):949-57.

PMID:
16732373
18.

Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study.

McKenna K, Koren G, Tetelbaum M, Wilton L, Shakir S, Diav-Citrin O, Levinson A, Zipursky RB, Einarson A.

J Clin Psychiatry. 2005 Apr;66(4):444-9; quiz 546.

PMID:
15816786
19.

Fetal outcome following roxithromycin exposure in early pregnancy.

Chun JY, Han JY, Ahn HK, Choi JS, Koong MK, Nava-Ocampo AA, Koren G.

J Matern Fetal Neonatal Med. 2006 Mar;19(3):189-92.

PMID:
16690513
20.

Maternal fever and birth outcome: a prospective study.

Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL.

Teratology. 1998 Dec;58(6):251-7.

PMID:
9894674

Supplemental Content

Support Center